» Articles » PMID: 30696680

Comparison of Intravenous, Topical or Combined Routes of Tranexamic Acid Administration in Patients Undergoing Total Knee and Hip Arthroplasty: a Meta-analysis of Randomised Controlled Trials

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Jan 31
PMID 30696680
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to compare the effects of intravenous, topical and combined routes of tranexamic acid (TXA) administration on blood loss and transfusion requirements in patients undergoing total knee arthroplasty (TKA) and total hip arthroplasty (THA).

Design: This was a meta-analysis of randomised controlled trials (RCT) wherein the weighted mean difference (WMD) and relative risk (RR) were used for data synthesis applied in the random effects model. Stratified analyses based on the surgery type, region, intravenous and topical TXA dose and transfusion protocol were also conducted. The main outcomes included intraoperative and total blood loss volume, transfusion rate, low postoperative haemoglobin (Hb) level and postoperative Hb decline. However, the secondary outcomes included length of hospital stay (LOS) and/or occurrence of venous thromboembolism (VTE).

Setting: We searched the PubMed, Embase and Cochrane CENTRAL databases for RCTs that compared different routes of TXA administration.

Participants: Patients undergoing TKA or THA.

Interventions: Intravenous, topical or combined intravenous and topical TXA.

Results: Twenty-six RCTs were selected, and the intravenous route did not differ substantially from the topical route with respect to the total blood loss volume (WMD=30.92, p=0.31), drain blood loss (WMD=-34.53, p=0.50), postoperative Hb levels (WMD=-0.01, p=0.96), Hb decline (WMD=-0.39, p=0.08), LOS (WMD=0.15, p=0.38), transfusion rate (RR=1.08, p=0.75) and VTE occurrence (RR=1.89, p=0.15). Compared with the combined-delivery group, the single-route group had significantly increased total blood loss volume (WMD=198.07, p<0.05), greater Hb decline (WMD=0.56, p<0.05) and higher transfusion rates (RR=2.51, p<0.05). However, no significant difference was noted in the drain blood loss, postoperative Hb levels and VTE events between the two groups. The intravenous and topical routes had comparable efficacy and safety profiles.

Conclusions: The combination of intravenous and topical TXA was relatively more effective in controlling bleeding without increased risk of VTE.

Citing Articles

Tranexamic acid: single topical application for femoral neck fractures treated with arthroplasty results in lowest blood loss.

Anna K, Rottinger T, Lisitano L, Koenemann N, Forch S, Mayr E Eur J Trauma Emerg Surg. 2025; 51(1):31.

PMID: 39838163 PMC: 11750898. DOI: 10.1007/s00068-024-02675-9.


The efficacy and safety of topical combined with intravenous administration of tranexamic acid in spine surgery: a systematic review and meta-analysis.

Xie C, Ren Y, Chen X, Zhu Y, Jiang J, Lu B BMC Musculoskelet Disord. 2024; 25(1):1074.

PMID: 39725950 PMC: 11673842. DOI: 10.1186/s12891-024-08191-6.


Impact of tranexamic acid use in total hip replacement patients: A systematic review and meta-analysis.

Liu H, Lee S J Orthop. 2024; 60:125-133.

PMID: 39411506 PMC: 11472018. DOI: 10.1016/j.jor.2024.08.004.


Perioperative bleeding control in total hip arthroplasty: hemostatic powder vs. tranexamic acid-a prospective randomized controlled trial.

Wakasa J, Iwakiri K, Ohta Y, Minoda Y, Kobayashi A, Nakamura H Arch Orthop Trauma Surg. 2024; 144(8):3797-3805.

PMID: 39105837 DOI: 10.1007/s00402-024-05475-3.


The Effect of Intravenous Tranexamic Acid on Perioperative Blood Loss, Transfusion Requirements, Verticalization, and Ambulation in Total Knee Arthroplasty: A Randomized Double-Blind Study.

Jovanovic G, Lukic-Sarkanovic M, Lazetic F, Tubic T, Lendak D, Uvelin A Medicina (Kaunas). 2024; 60(7.

PMID: 39064612 PMC: 11279079. DOI: 10.3390/medicina60071183.


References
1.
Digas G, Koutsogiannis I, Meletiadis G, Antonopoulou E, Karamoulas V, Bikos C . Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol. 2015; 25(7):1181-8. DOI: 10.1007/s00590-015-1664-8. View

2.
Drosos G, Ververidis A, Valkanis C, Tripsianis G, Stavroulakis E, Vogiatzaki T . A randomized comparative study of topical versus intravenous tranexamic acid administration in enhanced recovery after surgery (ERAS) total knee replacement. J Orthop. 2016; 13(3):127-31. PMC: 4821446. DOI: 10.1016/j.jor.2016.03.007. View

3.
Wang Z, Shen X . The efficacy of combined intra-articular and intravenous tranexamic acid for blood loss in primary total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2017; 96(42):e8123. PMC: 5662361. DOI: 10.1097/MD.0000000000008123. View

4.
Zhang L, Ma J, Kuang M, Zhao J, Wang Y, Lu B . Comparison of oral versus intravenous application of tranexamic acid in total knee and hip arthroplasty: A systematic review and meta-analysis. Int J Surg. 2017; 45:77-84. DOI: 10.1016/j.ijsu.2017.07.097. View

5.
Dunn C, Goa K . Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57(6):1005-32. DOI: 10.2165/00003495-199957060-00017. View